Logo-bma

Aims & Scope
Biomedicine Advances
 is an international, peer-reviewed, open-access journal published quarterly. The journal is dedicated to advancing high-quality basic, mechanistic, translational, and clinical research on molecular pathways, biomarkers, and therapeutic innovation in major non-communicable diseases (NCDs). It prioritises studies that connect experimental findings with disease prevention, diagnosis, prognosis, or treatment, particularly in cancer, cardiometabolic disorders, renal disease, and neurodegenerative diseases.

The journal welcomes original research articles reporting preclinical and clinical investigations, as well as systematic reviews, scoping reviews, high-quality narrative reviews by recognised experts, brief reports, and short communications that contribute to the understanding, prevention, diagnosis, and treatment of NCDs.


Acceptance Rate: 35%
Submission to First Decision: 20 Days
Received to Acceptance: 60 Days
Acceptance to Publication: 40 Days
*Average article statistics from the last 12 months of data.

In collaboration with